Publications by authors named "A K Sgibnev"

The improvement of the specific pharmacological activity of agents with antimicrobial and antiprotozoal properties (e.g. metronidazole, MET) is of interest for clinical applications in the treatment of bacterial infections.

View Article and Find Full Text PDF

To study how indigenous or probiotic-introduced lactobacilli affect the sensitivity (estimated as the proportion of surviving, apoptotic, and nonapoptotic deaths) of vaginal epithelial cells obtained from HPV-negative and HPV-positive patients to oxidative damage. The tendency to resist oxidative damage in vaginal epithelial cells of 147 HPV-positive and 59 HPV-negative patients with physiological or suboptimal levels of Lactobacillus was evaluated. Adaptation of cell to curb the oxidative damage in 146 HPV positive and 41 HPV negative with probiotic (Lacticaseibacillus rhamnosus Lcr35) supplementation and without was studied.

View Article and Find Full Text PDF

The development of polymeric carriers based on partially deacetylated chitin nanowhiskers (CNWs) and anionic sulfated polysaccharides is an attractive strategy for improved vaginal delivery with modified drug release profiles. This study focuses on the development of metronidazole (MET)-containing cryogels based on carrageenan (CRG) and CNWs. The desired cryogels were obtained by electrostatic interactions between the amino groups of CNWs and the sulfate groups of CRG and by the formation of additional hydrogen bonds, as well as by entanglement of carrageenan macrochains.

View Article and Find Full Text PDF

We studied the effects of IL-1β, IL-8, TNFα, and prostaglandin E2α in concentrations typically observed in health and during inflammation on the growth of vaginal microbiota and its resistance to factors inhibiting the synthesis of proteins, nucleic acids, and peptidoglycans. An increase in the cytokine levels, characteristic of inflammation, inhibits the growth of Lactobacillus population and improves its resistance to adverse factors. The growth of the population of opportunistic microorganisms (S.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to see if probiotics could enhance the effectiveness of antimicrobial therapy for women with Trichomonas vaginalis (TV) and bacterial vaginosis (BV).
  • Ninety women were divided into two groups: one received metronidazole plus vaginal probiotics, while the other received metronidazole plus a placebo.
  • Results showed that the probiotic group had significantly higher cure rates for both TV (88.6% vs. 42.9%) and BV (63.6% vs. 11.9%), alongside improvements in vaginal health indicators by day four of treatment.
View Article and Find Full Text PDF